drugset / Trial / NCT01373931
A Study of LY2216684 in Healthy Females
RandomizedCrossoverSingle-blindTreatment
Summary
This study involves a single dose of 18 milligrams (mg) LY2216684 taken as 1 or 2 tablets by mouth. The study will evaluate effect of LY2216684 on the pharmacokinetics of an oral contraceptive Ortho Cyclen®. This study will run approximately 93 days.
Timeline
- Start
- 2011-06
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norgestimate | Small molecule | 250 ug | Oral |
| Subject | edivoxetine | Small molecule | 18 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 35 ug | Oral |